New York Life Investment Management LLC Trims Stake in Henry Schein, Inc. $HSIC

New York Life Investment Management LLC lowered its position in Henry Schein, Inc. (NASDAQ:HSIC) by 1.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 28,063 shares of the company’s stock after selling 433 shares during the quarter. New York Life Investment Management LLC’s holdings in Henry Schein were worth $2,050,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Steph & Co. purchased a new stake in shares of Henry Schein in the second quarter valued at $44,000. CX Institutional raised its stake in shares of Henry Schein by 107.3% in the second quarter. CX Institutional now owns 651 shares of the company’s stock valued at $48,000 after acquiring an additional 337 shares during the period. TD Private Client Wealth LLC raised its stake in shares of Henry Schein by 103.0% in the second quarter. TD Private Client Wealth LLC now owns 668 shares of the company’s stock valued at $49,000 after acquiring an additional 339 shares during the period. Whittier Trust Co. raised its stake in shares of Henry Schein by 714.3% in the first quarter. Whittier Trust Co. now owns 798 shares of the company’s stock valued at $55,000 after acquiring an additional 700 shares during the period. Finally, Quarry LP purchased a new stake in shares of Henry Schein in the first quarter valued at $71,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Trading Up 0.5%

NASDAQ HSIC opened at $63.20 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The company has a market capitalization of $7.66 billion, a price-to-earnings ratio of 20.39, a price-to-earnings-growth ratio of 2.06 and a beta of 0.81. The company’s 50-day simple moving average is $66.19 and its two-hundred day simple moving average is $68.50. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). The business had revenue of $3.24 billion for the quarter, compared to analysts’ expectations of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company’s revenue for the quarter was up 3.3% on a year-over-year basis. During the same period last year, the business posted $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Equities analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on HSIC shares. Barrington Research reissued an “outperform” rating and issued a $78.00 target price on shares of Henry Schein in a research note on Wednesday, October 22nd. Evercore ISI raised shares of Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 price target on the stock in a research note on Tuesday, August 26th. Wall Street Zen downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th. Leerink Partners set a $75.00 price target on shares of Henry Schein in a research note on Monday, July 14th. Finally, Robert W. Baird reaffirmed a “neutral” rating and issued a $72.00 price target (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Five research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $76.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.